Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Companion Dx Draft Guidance: Broad In Scope, Limited In Detail

This article was originally published in The Gray Sheet

Executive Summary

FDA's draft guidance on the development of companion diagnostics for drug therapies, released July 12, delivers on a promise to publicly outline how it will address review of those products, but at only 12 pages, it has left some in industry longing for more insight.

You may also be interested in...



Drug/Diagnostic Co-Development Guidance Coming Soon, But Could Be Outdated Quickly

Tests that look for many markers at one time “may completely change” the paradigm for companion diagnostics, CDRH’s Elizabeth Mansfield says.

Drug/Diagnostic Co-Development Guidance Coming Soon, But Could Be Outdated Quickly

Tests that look for many markers at one time “may completely change” the paradigm for companion diagnostics, CDRH’s Elizabeth Mansfield says.

FDA On Personalized Medicine: Don’t Skimp On Diagnostic Quality Development

A CDRH representative tells a conference on drug/diagnostic co-development that it doesn’t matter how well designed a study for a therapeutic agent is if the accompanying biomarker-targeted test is not reliable and uniformly implemented.

Related Content

Topics

UsernamePublicRestriction

Register

LL1133148

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel